Roche Influenza Information
Blister strip containing Tamiflu capsules
Roche is working closely with the World Health Organization (WHO) and Governments around the world to make the oral antiviral medication Tamiflu available to patients in need following the increased reports of outbreaks of swine flu. The WHO and US CDC report Tamiflu is active against this new swine flu virus A(H1N1).
| Title | Download |
|---|---|
| Media Release September 13, 2009: Two new studies report increased survival rates in Tamiflu-treated patients with avian flu (H5N1) and severe seasonal flu | |
| Media Release July 1, 2009: Roche launches novel program to ease Tamiflu access to developing economies | |
| Media Release May 12, 2009: Roche provides additional donation of 5.65 million packs of Tamiflu to World Health Organization | |
| Media Release May 02, 2009: Roche rapidly responds to WHO request to deploy Rapid Response Stockpiles of Tamiflu to tackle global emergence of a new H1N1 influenza A strain - swine flu | |
| Media Release April 30, 2009: Roche responds to WHO move to influenza pandemic alert phase 5 | |
| Media Release April 29, 2009: Roche steps up preparedness level in response to WHO’s increase to pandemic alert phase 4 | |
| Roles and Responsibilities of Roche and Other Stakeholders | English |
Factsheets: | |
| Pandemics and antivirals | |
| Identifying counterfeit product | |
| Tamiflu EU patient information leaflet | |
| Roche Pandemic Preparedness |